Abstract
The diagnostic efficacy of 99mTc-citrate brain scintigraphy was assessed in 22 patients with proven brain lesions. All patients were given 99mTc-DTPA and then 2 days later, 99mTc-citrate. Our results show a superior diagnostic efficacy of the 99mTc-DTPA test in detecting brain lesions both of vascular and neoplastic type, especially when the lesions have a poor blood supply.
Similar content being viewed by others
References
Benes I, Heinzel F, Marwick G, Oppermann HC (1975) Technectiumcitrate als neues Radiopharmakin in der Tumor Diagnostik. Strahlentherapie (Sonderb) 74:107–116
Björnsson OG, Petursson E, Sigurbjörnsson B, Davidsson D (1978) Over-all accuracy of 99mTc-pertechnetate brain scanning for brain tumors Study of 471 patients. Nuclear Medicine 17:249–253
Ectors M, Abramovici J, Jonckheer MH (1975) Comparative study of 99mTc-citrate, 99mTc-diphosphonate and 99mTc-pertechnetate in brain scintigraphy. J Nucl Med 16:526
Rollo DF, Cavalieri RR, Born M, Blei L, Chew M (1977) Comparative evaluation of 99mTc-GH, 99mTcO4, and 99mTc-DTPA as brain imaging agents. Radiology 123:379–383
Sager WD, Thalhammer M, Fueger GF (1977) Vergleichende Hirnszintigraphie mit 99mTc-pertechnetate and 99mTc-Zitrat. Nuclear Medicine 16:257–259
Silberstein EB (1978) Optimizing brain scan sensitivity J Nucl Med 19:561–562
Witcofsky RL, Maynard CD, Roper TJ (1967) A comparative analysis of the accuracy of the technetium 99mTc-pertechnetate brain scan: follow-up of 1,000 patients. J Nucl Med 8:187–196
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Castagnoli, A., Pupi, A., Guizzardi, G. et al. Brain scintigraphy with 99mTc-citrate and 99mTc-DTPA: A clinical comparison of the results. Eur J Nucl Med 7, 184–186 (1982). https://doi.org/10.1007/BF00443929
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00443929